Dengue
152
15
21
91
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
32 trials with published results (21%)
Research Maturity
91 completed trials (60% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.9%
9 terminated out of 152 trials
91.0%
+4.5% vs benchmark
8%
12 trials in Phase 3/4
35%
32 of 91 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 91 completed trials
Clinical Trials (152)
Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years.
Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)
A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)
Efficacy and Safety of Carica Papaya in Dengue Fever: A Randomised Clinical Trial
Gut Leakage' in Dengue
Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative)
Effects Of A Rehabilitation Protocol On Muscle Strength, Muscle Fatigue And Postural Control In Post-Dengue And Chikungunya Patients
Adaptive Dengue Antiviral Platform Trial
Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human Mobility
Therapeutics for Moderate and Severe Dengue
Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in Vietnam
Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian Communities
Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale
A Controlled Human Infection Model of Dengue
Characterizing Humoral Immune Response to Mosquito Bites
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Immunogenicity of an Intradermal Qdenga Vaccine Among Healthy Volunteers
Anakinra in Dengue With Hyperinflammation ( AnaDen )